About the American Council of Cannabis Medicine
The American Council of Cannabis Medicine (ACCM) is the national trade group whose purpose is advocating and serving as the voice for the medical-cannabis industry in Washington, D.C., and supporting emerging medical-cannabis states. The Council’s mission is to: influence important legislative and regulatory policies and government programs that affect medical cannabis; communicate with Washington DC and state policymakers and the media about medical-cannabis, usage, research, processing and products; affect domestic policy to maintain and expand opportunities for U.S. patients, providers, and physicians; and enhance, promote and protect the image and reputation of this newly emerging vital industry.
ACCM member organizations are industry producer/processors, medical-cannabis pharmacies and dispensaries, practicing physician groups, patient, customer/client user-related groups, traditional pharma companies, and allied industry firms. The producer/processors account for most of the medical cannabis produced in state-licensed programs. ACCM was established in 2016 as a working group of stakeholders and has become a full stand-alone public-facing organization just a few years later. ACCM maintains headquarters in the nation’s capital to provide a permanent voice exclusively for medical cannabis and to better represent the industry and its emerging products as serious medical solutions supporting ongoing clinical research and advancements.
Please call us with any questions:
American Council of Cannabis Medicine
601 Pennsylvania Ave. NW
South Building, Suite 900
Washington, D.C., 20004
United States of America
The America Council of Cannabis Medicine provides timely new alerts and releases.
ACCM is organized as a 501c4 Section 501(c)(4) of the Internal Revenue Code provides for the exemption of social welfare organizations, which are not organized for profit and no part of the net earnings of which inures to the benefit of any private shareholder or individual. An
organization that otherwise qualifies for exemption under Internal Revenue Code section 501c4. will not be disqualified merely because it engages in some political activity. In addition, the organization may engage in lobbying that is germane to accomplishing its exempt
purpose without jeopardizing its exemption.
Supporting the 21st Century Medical Innovation
Copyright © 2022 American Council of Cannabis Medicine - All Rights Reserved.
American Council of Cannabis Medicine 202-349-9650